AstraZeneca delays filing for US approval for COVID vaccine
Al Jazeera
The Anglo-Swedish drugmaker said it intends to seek US authorisation for its shot in the coming weeks.
AstraZeneca said Friday that it intends to seek United States authorisation for its COVID-19 vaccine in the “coming weeks”, acknowledging a delay in the much-anticipated filing that had been expected by mid-April. The Anglo-Swedish drugmaker revealed the new timetable as it released first-quarter financial results, which showed that the company delivered 68 million doses of the vaccine to the European Union, United Kingdom and other countries in the first three months of the year. The company said it was continuing to work on its application to the US Food and Drug Administration (FDA), noting the “substantial size of the file” that will include data from US trials as well all other studies completed so far and real-world data collected from use of the vaccine in other countries.
The region is on edge as Trump’s 48-hour deadline for Iran to reopen the Strait of Hormuz or face attacks on power plants nears.
Rescue teams headed to the site of a suspected Israeli attack in Gaza City to control the blaze.
Energy crunch prompted by Iran war poses ‘major threat’ to global economy, Fatih Birol says.
The Argentinian star forward records his 901st career goal as Inter Miami beat New York City FC at Yankee Stadium.
LaGuardia shut down after Air Canada Express plane hits ground vehicle upon landing from Montreal.
The Italian rider is now 11 points clear of Aprilia teammate Jorge Martin in the riders’ standings after two rounds.
Key indexes in Japan, South Korea and Hong Kong tumble as Iran threatens attacks on energy infrastructure across region.
Gregoire headed a list uniting the traditional left, the Greens and the Communists to victory in French capital.
Much of the top leadership has been eliminated, but the country is still fighting.
Real stay within four points of league leaders Barcelona with hard-fought win in Madrid derby.